Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: A meta-analysis

EuroIntervention

Volumn 13, Issue 4, 2017, Pages 483-489

  Cassese, Salvatore ^a   Ndrepepa, Gjin ^a   Kufner, Sebastian ^a   Byrne, Robert A ^a   Giacoppo, Daniele ^a   Ott, Ilka ^a   Laugwitz, Karl Ludwig ^b,c   Schunkert, Heribert ^a,c   Kastrati, Adnan ^a,c   Fusaro, Massimiliano ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Drug eluting balloon; Femoropopliteal disease; In stent restenosis

Indexed keywords

PACLITAXEL;

AGED; ANKLE BRACHIAL INDEX; ARTICLE; COMPARATIVE EFFECTIVENESS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DISEASE CLASSIFICATION; DRUG COATED BALLOON ANGIOPLASTY; FEMALE; FEMORAL ARTERY; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; ODDS RATIO; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RUTHERFORD CLASS IMPROVEMENT; TARGET LESION REVASCULARIZATION; TREATMENT OUTCOME; DRUG ELUTING STENT; GRAFT OCCLUSION; MIDDLE AGED; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROCEDURES; PROSTHESIS DESIGN; STENOSIS, OCCLUSION AND OBSTRUCTION;

AGED; ANGIOPLASTY, BALLOON; CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; FEMALE; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSTHESIS DESIGN; TREATMENT OUTCOME;

EID: 85026522784     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJ-D-16-00735     Document Type: Article

References (32)

1. European Stroke Organization, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V, Roffi M, Rother J, Sievert H, van Sambeek M, Zeller T; ESC Committee for Practice Guidelines. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32: 2851-906.
2. Anderson JL, Halperin JL, Albert N, Bozkurt B, Brindis RG, Curtis LH, Demets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127: 1425-43.
3. Tosaka A, Soga Y, Iida O, Ishihara T, Hirano K, Suzuki K, Yokoi H, Nanto S, Nobuyoshi M. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol. 2012;59: 16-23.
4. Singh GD, Armstrong EJ, Laird JR. Femoropopliteal in-stent restenosis: Current treatment strategies. J Cardiovasc Surg (Torino). 2014;55: 325-33.
5. Cortese B, Granada JF, Scheller B, Schneider PA, Tepe G, Scheinert D, Garcia L, Stabile E, Alfonso F, Ansel G, Zeller T. Drug-coated balloon treatment for lower extremity vascular disease intervention: An international positioning document. Eur Heart J. 2016;37: 1096-103.
6. Cassese S, Byrne RA, Ott I, Ndrepepa G, Nerad M, Kastrati A, Fusaro M. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: A meta-analysis of randomized trials. Circ Cardiovasc Interv. 2012;5: 582-9.
7. Stabile E, Virga V, Salemme L, Cioppa A, Ambrosini V, Sorropago G, Tesorio T, Cota L, Popusoi G, Pucciarelli A, Biamino G, Rubino P. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol. 2012;60: 1739-42.
8. Schmidt A, Piorkowski M, Gorner H, Steiner S, Bausback Y, Scheinert S, Banning-Eichenseer U, Staab H, Branzan D, Varcoe RL, Scheinert D. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry. JACC Cardiovasc Interv. 2016;9: 715-24.
9. Krankenberg H, Tubler T, Ingwersen M, Schluter M, Scheinert D, Blessing E, Sixt S, Kieback A, Beschorner U, Zeller T. Drug-Coated Balloon Versus Standard Balloon for Superficial Femoral Artery In-Stent Restenosis: The Randomized Femoral Artery In-Stent Restenosis (FAIR) Trial. Circulation. 2015;132: 2230-6.
10. Kinstner CM, Lammer J, Willfort-Ehringer A, Matzek W, Gschwandtner M, Javor D, Funovics M, Schoder M, Koppensteiner R, Loewe C, Ristl R, Wolf F. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial. JACC Cardiovasc Interv. 2016;9: 1386-92.
11. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327: 557-60.
12. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA. 1999;282: 1054-60.
13. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001;323: 101-5.
14. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25: 3443-57.
15. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295: 676-80.
16. Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008;61: 64-75.
17. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med. 2009;151: 264-9, W64.
18. Liistro F, Angioli P, Porto I, Ricci L, Ducci K, Grotti S, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L. Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: The DEBATE-ISR study. J Endovasc Ther. 2014;21: 1-8.
19. Tepe G. Cotavance paclitaxel-coated balloon vs. uncoated balloon angioplasty for treatment of in-stent restenosis in SFA and the popliteal arteries: The COPACABANA trial. Oral presentation at Leipzig Interventional Course (LINC) 2015, January 27-30, 2015. Leipzig, Germany.
20. Gray BH, Buchan JA. The Treatment of Superficial Femoral Artery In-Stent Restenosis: The Jury Is Still Out. JACC Cardiovasc Interv. 2016;9: 1393-6.
21. Gongora CA, Shibuya M, Wessler JD, McGregor J, Tellez A, Cheng Y, Conditt GB, Kaluza GL, Granada JF. Impact of Paclitaxel Dose on Tissue Pharmacokinetics and Vascular Healing: A Comparative Drug-Coated Balloon Study in the Familial Hypercholesterolemic Swine Model of Superficial Femoral In-Stent Restenosis. JACC Cardiovasc Interv. 2015;8: 1115-23.
22. Yahagi K, Otsuka F, Sakakura K, Sanchez OD, Kutys R, Ladich E, Kolodgie FD, Virmani R, Joner M. Pathophysiology of superficial femoral artery in-stent restenosis. J Cardiovasc Surg (Torino). 2014;55: 307-23.
23. Brodmann M, Rief P, Froehlich H, Dorr A, Gary T, Eller P, Hafner F, Deutschmann H, Seinost G, Pilger E. Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: A controlled, randomized pilot trial. Cardiovasc Intervent Radiol. 2013;36: 69-74.
24. Dippel EJ, Makam P, Kovach R, George JC, Patlola R, Metzger DC, Mena-Hurtado C, Beasley R, Soukas P, Colon- Hernandez PJ, Stark MA, Walker C; EXCITE ISR Investigators. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: Initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovasc Interv. 2015;8: 92-101.
25. Laird JR Jr, Yeo KK, Rocha-Singh K, Das T, Joye J, Dippel E, Reddy B, Botti C, Jaff MR. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: Twelve-month results from the SALVAGE study. Catheter Cardiovasc Interv. 2012; 80: 852-9.
26. Zeller T, Dake MD, Tepe G, Brechtel K, Noory E, Beschorner U, Kultgen PL, Rastan A. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents. JACC Cardiovasc Interv. 2013;6: 274-81.
27. Bosiers M, Deloose K, Callaert J, Verbist J, Hendriks J, Lauwers P, Schroe H, Lansink W, Scheinert D, Schmidt A, Zeller T, Beschorner U, Noory E, Torsello G, Austermann M, Peeters P. Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: Twelve-month results from a multicenter randomized trial. J Endovasc Ther. 2015;22: 1-10.
28. Iida O, Takahara M, Soga Y, Hirano K, Yamauchi Y, Zen K, Kawasaki D, Nanto S, Yokoi H, Uematsu M; ZEPHYR Investigators. The Characteristics of In-Stent Restenosis After Drug-Eluting Stent Implantation in Femoropopliteal Lesions and 1-Year Prognosis After Repeat Endovascular Therapy for These Lesions. JACC Cardiovasc Interv. 2016;9: 828-34.
29. Grotti S, Liistro F, Angioli P, Ducci K, Falsini G, Porto I, Ricci L, Ventoruzzo G, Turini F, Bellandi G, Bolognese L. Paclitaxel- Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study. J Endovasc Ther. 2016;23: 52-7.
30. Joner M, Nakazawa G, Bonsignore C, Acampado E, Steigerwald K, Merl S, Vallbracht T, Kolodgie FD, Virmani R. Histopathologic evaluation of nitinol self-expanding stents in an animal model of advanced atherosclerotic lesions. EuroIntervention. 2010;5: 737-44.
31. Gandini R, Del Giudice C, Merolla S, Morosetti D, Pampana E, Simonetti G. Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: A single-center, prospective, randomized study. J Endovasc Ther. 2013;20: 805-14.
32. Dick P, Sabeti S, Mlekusch W, Schlager O, Amighi J, Haumer M, Cejna M, Minar E, Schillinger M. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: Initial experience. Radiology. 2008;248: 297-302.